Influence of intraperitoneal 5-fluorouracil plus folinic acid on the healing of colonic anastomoses in rats

被引:18
|
作者
Kanellos, I [1 ]
Kavouni, A [1 ]
Zaraboukas, T [1 ]
Odisseos, C [1 ]
Galovatsea, K [1 ]
Dadoukis, I [1 ]
机构
[1] ARISTOTELIAN UNIV THESSALONIKI,DEPT SURG 4,GR-54006 THESSALONIKI,GREECE
关键词
anastomoses; 5-fluorouracil; colon; folinic acid; wound healing;
D O I
10.1159/000129479
中图分类号
R61 [外科手术学];
学科分类号
摘要
We studied the effects of intraperitoneal 5-fluorouracil (5-FU) administration with or without the addition of folinic acid (FA) on the healing of colonic anastomoses in rats immediately after surgery. Sixty-three male Wistar rats were subjected to colonic anastomosis. During surgery, the rats were randomized into one of three groups. Therapy was administered as an intraoperative intraperitoneal injection which was repeated once daily for the first 2, postoperative days. A 0.9% NaCl solution was administered to the rats in the control group. In group 2, we injected 5-FU (20 mg/kg/day) and in group 3 5-FU (20 mg/kg/day) plus FA (2 mg/kg/day). The rats were sacrificed on postoperative days 3, 5 or 8. Rupture of the anastomosis was significantly higher in the rats of groups 2 and 3, compared with the control group (p < 0.05). There were, however, no differences between groups 2 and 3. Formation of adhesions and abscesses was more common in groups 2 and 3 than in the control group for all study days. A significant difference in the anastomotic bursting pressure was measured for the control group in comparison to groups 2 and 3 on days 5 and 8 (p < 0.05). Histologic evaluation also showed a more profound inflammatory reaction and delayed healing of the anastomoses in groups 2 and 3, compared to the control group. Therefore, the perioperative intraperitoneal administration of 5-FU can inhibit the healing of colonic anastomoses in rats. The addition of an intraperitoneal injection of FA does not aggravate this negative effect.
引用
收藏
页码:374 / 379
页数:6
相关论文
共 50 条
  • [31] The combination of 5-fluorouracil and folinic acid in the treatment of breast cancer: The emerging role
    Zaniboni, A
    CANCER JOURNAL - FRANCE, 1996, 9 (02): : 77 - 78
  • [32] ANALYSIS OF THE STABILITY OF 5-FLUOROURACIL (NEW FRENCH PREPARATION)-FOLINIC ACID ADMIXTURES
    MILANO, G
    RENEE, N
    BULLETIN DU CANCER, 1995, 82 (03) : 189 - 195
  • [33] Adjuvant chemotherapy with 5-fluorouracil and folinic acid in colorectal cancer: Evaluation of toxicity
    Hartung, G
    Queisser, W
    Diezler, P
    Hagmuller, E
    Edler, L
    Jacob, I
    Wojatschek, C
    Seifert, A
    Weiss, H
    Weh, HJ
    Hoffknecht, M
    Clemens, MR
    Fritze, D
    Katz, R
    Harle, M
    ONKOLOGIE, 1996, 19 (01): : 62 - 67
  • [34] Relief of jaundice by 5-fluorouracil and folinic acid in patients with recurrent gastric cancer
    Kajiyama, Y
    Tsurumaru, M
    Udagawa, H
    Tsutsumi, K
    Kinoshita, Y
    Akiyama, H
    SURGICAL ONCOLOGY-OXFORD, 1996, 5 (04): : 177 - 181
  • [35] Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
    Pierpaolo Correale
    Fabio Fulfaro
    Stefania Marsili
    Giuseppe Cicero
    Eugenia Bajardi
    Chiara Intrivici
    Giuseppe Vuolo
    Antonio Ferdinando Carli
    Michele Caraglia
    Salvatore Del Prete
    Ettore Greco
    Nicola Gebbia
    Guido Francini
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 563 - 568
  • [36] Stability of 5-fluorouracil-folinic acid mixture: influence of concentrations, container and form of folinic acid
    Lokiec, F
    Amirault, P
    Bonnans, H
    Gauzan, MF
    Sauvage, N
    Santoni, J
    BULLETIN DU CANCER, 1999, 86 (11) : 946 - 954
  • [37] Influence of Preoperative Feeding on the Healing of Colonic Anastomoses in Malnourished Rats
    Goncalves, Carolina Gomes
    Groth, Anne Karoline
    Ferreira, Marcelo
    Matias, Jorge Eduardo F.
    Coelho, Julio Cezar U.
    Campos, Antonio Carlos L.
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2009, 33 (01) : 83 - 89
  • [38] 5-fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: A prospective, randomized pilot trial
    Breul, J
    Jakse, G
    Forster, G
    Lampel, A
    Rohani, A
    Hartung, R
    EUROPEAN UROLOGY, 1997, 32 (03) : 280 - 283
  • [39] Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer
    Correale, P
    Fulfaro, F
    Marsili, S
    Cicero, G
    Bajardi, E
    Intrivici, C
    Vuolo, G
    Carli, AF
    Caraglia, M
    Del Prete, S
    Greco, E
    Gebbia, N
    Francini, G
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (06) : 563 - 568
  • [40] Phosphatidylcholine does not protect rats against 5-fluorouracil/folinic acid-induced damage of the intestinal luminal mucosa
    Fittkau, M
    Gerlach, R
    Schmoll, HJ
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2002, 128 (02) : 80 - 84